Answers are grounded in this paper and cite their sources.
GCK-MODY is generally considered a benign form of diabetes with mild, stable hyperglycemia, although its detailed glycemic profile remains incompletely characterized. This study aimed to better characterize the glycemic profile of individuals with GCK-MODY using continuous glucose monitoring (CGM) compared with healthy controls. A cross-sectional, case–control study was conducted including 21 individuals with genetically confirmed GCK-MODY and 10 controls without diabetes who underwent continuous glucose monitoring (CGM). All GCK-MODY participants achieved time in range > 70%; however, time in tight range (TITR) was lower compared to controls (78% vs. 96%, p < 0.001), with higher mean glucose, glucose management indicator, and time above range. None in the GCK-MODY group attained TITR > 96%, a benchmark reached by all controls. No clear genotype–phenotype pattern was observed. Four GCK variants were characterized, including one previously unreported variant. CGM may provide additional insights into glucose distribution and phenotypic characteristics in GCK-MODY. Larger longitudinal studies are needed to establish the clinical relevance of these findings.
No takes yet. Share an insight, caveat, or question.
Canzian et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: